Alzheimer’s, ICNIRP & 5G: Report from the Science & Wireless 2016, Melbourne, Australia

UPDATE March 6, 2017: This post is also available in German

************

Science & Wireless 2016’ was hosted at the Royal Melbourne Institute of Technology (RMIT) in Melbourne, Victoria, Australia, on November 22, 2016. Program of the event and links to all presentations are available here.

The event consisted of two parts. The first part, the ‘RF & Alzheimer’s Disease’, focused on the possibility of developing novel medical treatment of Alzheimer’s disease by exposing patients’ brains to RF-EMF. In the second part, the ‘Radiofrequency Guidelines’, were presented a progress report on the development of ICNIRP guidelines for the exposures to RF-EMF and the time-table for the development and implementation of the 5G technology.

The full report is available here: leszczynski-report-from-science-wireless-2016

Here are the summary comments from the Report:

Final comments concerning the Science & Wireless 2016

I have participated in the Science & Wireless events in 2010, 2012, 2014, and 2015 and in the 2012 I was one of the invited speakers.

After my first encounter with the Science & Wireless, in 2010 I wrote a very enthusiastic post in my BRHP blog about this kinds of events, gathering scientists, regulators, industry and users of the technology.

Unfortunately, my enthusiastic opinion of the Science & Wireless event has vanished over the time. In recent years the Science & Wireless events cannot be called anymore a ‘Community Interaction’ events. They become events where science, this acceptable by the industry and by the ICNIRP, is presented for the benefit of industry and the ICNIRP. ‘Community representatives’, questioning validity of science evaluation by industry and by ICNIRP, have been entirely excluded.

The take-away message from the Science and Wireless 2016:

  • RF-EMF exposures affect beta-amyloid proteins in brains of transgenic mice
  • Effect on beta-amyloid protein is caused by non-thermal mechanism
  • It is still unclear whether observed beneficial effects of RF-EMF in transgenic mice will apply to human AD
  • ICNIRP stubbornly disregards all evidence concerning non-thermal effects of RF-EMF (ICNIRP’s acceptance of the existence of non-thermal effects would invalidate current safety limits)
  • ICNIRP, arbitrarily, without plausible scientific evidence, places skin among the less important parts of body that can be more exposed to RF-EMF
  • Skin should not be allowed to be placed by ICNIRP in the ‘limbs’ group of organs because this will allow the 5G technology to market devices with higher radiation exposure, irrespective of the proximity of these devices to human body – all energy of 5G device will be absorbed solely by the skin
  • Implementation of 5G technology goes fast ahead in spite of the complete lack of science on the 5G effects on skin biology
  • The Precautionary Principle is completely disregarded by the ICNIRP and industry

1 thought on “Alzheimer’s, ICNIRP & 5G: Report from the Science & Wireless 2016, Melbourne, Australia

  1. Pingback: Alzheimer’s, ICNIRP & 5G: Report from the Science & Wireless 2016, Melbourne, Australia - EMFSA

Leave a comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.